The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Effects of Pegorgotein on Neurologic Outcome of Patients With Severe Head Injury: A Multicenter, Randomized Controlled Trial
Abstract
OBJECTIVE: To evaluate outcome of patients with severe closed head injury treated with pegorgotein, a scavenger of oxygen-derived free radicals. DESIGN: Randomized, parallel, placebo-controlled, third-party-blind, multicenter trial, with a blinded, multicenter follow-up protocol. SETTING: Twenty-nine centers in the United States. PATIENTS: A total of 463 patients with severe closed head injury and a Glasgow Coma Scale score of 8 or less after resuscitation and stabilization. INTERVENTIONS: Patients received a single intravenous dose of placebo, 10 000 U/kg of pegorgotein, or 20 000 U/kg of pegorgotein within 8 hours after injury. OUTCOME MEASURES: The primary endpoint was the Glasgow Outcome Scale (GOS) score at 3 months after brain injury with GOS data trichotomized into good, fair, or poor outcome. Secondary efficacy endpoints included the Disability Rating Scale (DRS) and mortality. A secondary analysis was performed using GOS scores dichotomized into favorable and unfavorable outcomes. In a follow-up protocol at 6 months, GOS and DRS scores were again determined. RESULTS: Of 463 patients randomized, 162 received placebo; 149, pegorgotein 10 000 U/kg; and 152, pegorgotein 20 000 U/kg. Treatment groups were comparable with respect to demographic characteristics, mechanism of injury, and time to treatment. Pegorgotein was well tolerated at both dose levels. At month 3, the trichotomized analysis found no significant statistical difference in neurologic outcome between the pegorgotein and the placebo groups. Although differences were not statistically significant, there were more favorable outcomes and no increase in the number of deaths or vegetative states among the patients given pegorgotein, more subjects had good or favorable outcomes with the 10 000-U/kg dose than with the 20 000-U/kg dose or placebo, and less disability was observed with the 10 000-U/kg dose than with either the 20 000-U/kg dose or placebo. No differences in mortality rate or cause of death were found between the 10 000-U/kg and placebo groups at either month 3 or month 6. The only statistically significant difference between the groups was a decreased incidence of adult respiratory distress syndrome in the 10 000-U/kg group as compared with the placebo group (P<.015). CONCLUSIONS: In this clinical trial of 463 patients with severe head injury, no statistically significant difference in neurologic outcome or mortality was observed between patients treated with pegorgotein and those receiving placebo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Teasdale, G., & Jennett, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91639-0 · Cited by 13,215
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
Cited by
Antioxidant Therapy in Acute Central Nervous System Injury: Current State
Gilgun-Sherki, Y., Rosenbaum, Z., Melamed, E., & Offen, D. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.271 · Cited by 568
Lateral Fluid Percussion Brain Injury: A 15-Year Review and Evaluation
Thompson, H. J., Lifshitz, J., Marklund, N., Grady, M. S., Graham, D. I., Hovda, D. A., & McIntosh, T. K. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.42 · Cited by 528
Prognostic Value of Secondary Insults in Traumatic Brain Injury: Results from The IMPACT Study
McHugh, G. S., Engel, D. C., Butcher, I., Steyerberg, E. W., Lu, J., Mushkudiani, N., Hernández, A. V., Marmarou, A., Maas, A. I. R., & Murray, G. D. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0031 · Cited by 415
Prognosis and Clinical Trial Design in Traumatic Brain Injury: The IMPACT Study
Maas, A. I. R., Marmarou, A., Murray, G. D., Teasdale, S. G. M., & Steyerberg, E. W. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0024 · Cited by 355
Novel Pharmacologic Strategies in the Treatment of Experimental Traumatic Brain Injury: 1998
McINTOSH, T. K., JUHLER, M., & WIELOCH, T. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.731 · Cited by 298
Metadata
- Authors
- Young, B.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1996-08-21
- Volume
- 276
- Issue
- 7
- Pages
- 538
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2007044820
- Cited by
- 174
- References
- 2
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Pegorgotein on Neurologic Outcome of Patients With Severe Head Injury: A Multicenter, Randomized Controlled Trial. https://app.cochat.ai/papers/10.1001/jama.1996.03540070034027
- The paper
- Young, B. (1996). Effects of Pegorgotein on Neurologic Outcome of Patients With Severe Head Injury: A Multicenter, Randomized Controlled Trial. JAMA. https://doi.org/10.1001/jama.1996.03540070034027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.